Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples